NIH Weekly Funding Opportunities and Policy Notices
Funding Opportunity PAR-19-208 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity is to support important "legacy" resources developed as a result of NIGMS research activities that are central to the mission of NIGMS and demonstrate a high value to a community of researchers that NIGMS supports, but are no longer eligible for support under their original initiatives. It is also expected that these resources are not eligible for support by other Institutes'/Centers' funding opportunity announcements, and not yet self-sustaining or ready for commercialization. For this initiative, a resource is defined as a non-hypothesis-driven activity that is available to any qualified investigator and provides data, materials, tools, or services considered essential to making the most timely, high quality, and cost-efficient progress in a field. This funding opportunity is designed to support the continuation of existing resources, not to develop new ones. The support requested must be for funding of maintenance activities only, and not for research activities. Under this limited program, only NIGMS-sponsored "legacy" resources that cannot be renewed under their initial funding activity are eligible. Up to three years' support can be requested while plans to transition to a more permanent form of support are implemented.
Notice NOT-GM-19-020 from the NIH Guide for Grants and Contracts
Notice NOT-GM-19-019 from the NIH Guide for Grants and Contracts
Notice NOT-CA-19-030 from the NIH Guide for Grants and Contracts
Notice NOT-AI-19-050 from the NIH Guide for Grants and Contracts
Notice NOT-AI-19-049 from the NIH Guide for Grants and Contracts
Notice NOT-OD-19-088 from the NIH Guide for Grants and Contracts
Notice NOT-AI-19-048 from the NIH Guide for Grants and Contracts
Notice NOT-AI-19-047 from the NIH Guide for Grants and Contracts
Notice NOT-EY-19-011 from the NIH Guide for Grants and Contracts
Emerging Infectious Diseases Research Centers - Coordination Center (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-19-029 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for an Emerging Infectious Diseases Research Centers Coordination Center (EIDRC CC) for the Emerging Infectious Diseases Research Centers (EIDRC). The EIDRC CC will oversee and coordinate select aspects of each EIDRCs research project(s) involving data management, sample collection and storage, sharing of reagents, diagnostics, and resources, and will facilitate collaboration between the newly awarded EIDRCs, and other USG and international agencies, as appropriate.
Notice NOT-HG-19-016 from the NIH Guide for Grants and Contracts
Notice NOT-EY-19-018 from the NIH Guide for Grants and Contracts
Notice NOT-EY-19-017 from the NIH Guide for Grants and Contracts
Notice NOT-EY-19-016 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-19-207 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIAAA/NIDA R25 program is to support educational activities that foster a better understanding of biomedical, behavioral, and clinical research on alcohol and other substance use disorders and their implications. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Outreach. Specifically, this FOA will support projects designed to engage practicing health care professionals in education about current and emerging knowledge derived from scientific research on the neurobiology, epidemiology, prevention, and/or treatment of alcohol and other substance use disorders and related health conditions.
Funding Opportunity PAR-19-209 from the NIH Guide for Grants and Contracts. The objective of this Funding Opportunity Announcement (FOA) is to support the development of new and innovative on-demand, event -driven and long-acting systemic and non-systemic multipurpose prevention technologies (MPT). It supports development of MPTs that prevent HIV infection and pregnancy (hormonal and non-hormonal methods); sexually transmitted infections (STI) and pregnancy, and (HIV/STI) and non-HIV STI MPTs in cis and trans males and females of all ages. Applications for MPT development may involve pharmacokinetic (PK), pharmacodynamic (PD), safety and, drug-drug interactions (DDI) studies using drug development and formulation science supported by animal model testing. Also supported are biobehavioral and behavioral/social studies to identify MPT user-desired rheological and biophysical factors (look, feel, effectiveness, safety and duration of action) and other behavioral/social factors that could promote increased MPT adoption and use.
Notice NOT-NS-19-038 from the NIH Guide for Grants and Contracts
Notice NOT-ES-19-009 from the NIH Guide for Grants and Contracts
Funding Opportunity PA-19-205 from the NIH Guide for Grants and Contracts. The Office of Research on Women's Health (ORWH) announces the availability of administrative supplements to support interdisciplinary, transdisciplinary and multidisciplinary research focused on the effect of sex/gender influences at the intersection of several social determinants, including but not limited to: race/ethnicity, socioeconomic status, education, health literacy and other social determinants in human health and illness. This research includes preclinical, clinical, behavioral and translational studies with the specific purpose to provide Administrative Supplements to active NIH parent grants for one year to address health disparities among women of populations in the US who are understudied, underrepresented and underreported in biomedical research. The proposed research must address an area specified within Goal 1 and 2 of the new Trans-NIH Strategic Plan for Women's Health Research "Advancing Science for the Health of Women". These goals focus on advancing rigorous research that is relevant to the health of women (Goal 1) and developing methods and leveraging data sources to consider sex and gender influences that enhance research for the health of women (Goal 2). Projects must include a focus on one or more NIH-designated health disparities populations, which include Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asian Americans, Native Hawaiians and other Pacific Islanders, socioeconomically disadvantaged populations, underserved rural populations, and sexual and gender minorities (SGM). Combinations of one or more populations is also encouraged, e.g. socioeconomically disadvantaged sexual and gender minorities.